Press Releases


Aladdin Healthcare Technologies SE has launched its Health Risk Assessment Tool to Airbus (India) and Saregama (India)

BERLIN/LONDON, April 16, 2020 - Aladdin Healthcare Technologies SE (“Aladdin”, ISIN: DE000A12ULL2) launches, alongside an Indian based partner, its Health Risk Assessment Tool (HRA) for diabetes, cardiovascular health and COVID-19 to the India based employees of two global corporations Airbus (India) and Saregama (India).

OurHealthMate (OHM) has introduced the ’Health Risk Assessment Tool’ developed by Aladdin to its clients Airbus in India and Saregama India Ltd. as a part of the HealthCare management services portfolio for 2020-21. OHM is an accredited doctor-patient platform for clinical searches in India working with over 2,000 healthcare institutions and serving 30,000 doctors and over 32 million patients in its network.

The Aladdin Health Risk Assessment (HRA) tool combines artificial intelligence (AI) with risk analytics and will be available as both a web and mobile application. With this technological intervention, Airbus and Saregama will be able to have a better employee insight, coupled with a process that includes biometric testing to assess its workplace’s health insights and risks, as well as habits. Aladdin is delivering a new generation of healthcare management technology to the Indian market. At the same time, the AI suggests suitable further care measures and gives lifestyle advice to the employees directly.

The partnership between Aladdin and OHM provides a whole suite of healthcare services to all the employees of Airbus and Saregama in India. The services include Health Risk Assessment, Physical healthcare services including diagnostics, Counsellor services, etc. With the HRA tool in use, together it assists in taking informed decisions on future healthcare management initiatives for its employees as well as significant cost savings by directing the budgeting process in the right direction.

Aladdin’s health risk assessment application currently includes diabetes, cardiovascular health with COVID-19 to follow. The application has been integrated into OHMs platform which consists of 40 large corporate employee healthcare schemes. Airbus and Saregama are the first with more to follow.

Wade Menpes-Smith, CEO of Aladdin Healthcare Technologies SE comments: “This is not only a significant step for Aladdin with regards to its impact on the Indian market it will also form part of a risk prediction analytics for faster and superior underwriting of health and life insurance policies as well. We intend to roll out further innovative software solutions, especially in the area of age-related diseases such as Alzheimer’s Disease. We expect other major corporates within India to follow in adopting the HRA and subsequently implementing Aladdin’s platform in the future. This will result in revenues for Aladdin as the technology becomes a vital part of companies Healthcare management services portfolio.”

About Aladdin Healthcare Technologies SE

Aladdin Healthcare Technologies SE (and its wholly owned subsidiary Aladdin Healthcare Technologies Ltd.) is a leading developer of AI healthcare diagnostics and drug discovery applications that can accelerate both early stage disease diagnosis and the end-to-end drug discovery process. Aladdin targets aged related disease including a significant focus on Alzheimer’s disease. Aladdin accomplishes this by collaborating with numerous partners within the global healthcare ecosystem to confidentially and securely gather targeted data including, genome, tabular, MRI, PET, cognition and other lifestyle data. These datasets are then analysed by the award-winning AI team and used to develop proprietary AI tools that can assist healthcare professionals to more accurately and efficiently diagnose aged related diseases. This new diagnostic process will save significant time and costs for healthcare professionals. Additionally, the AI drug discovery platform will be used by pharmaceutical Companies to speed up drug development, clinical trials and predict outcomes more accurately.

About Saregama

Saregama India Ltd. is India’s oldest music label. In 1901, the company began operations by recording the first song in India. Apart from music, Saregama also produces films under the brand name Yoodlee Films and multi-language Television content. The company has expanded its catalogue to become the largest in-perpetuity global owner of both sound recording and publishing copyrights of Indian music across 14 different languages. Saregama owns music repertoires across Film music, Carnatic, Hindustani classical, Devotional etc. in all prominent Indian languages. For the first 100 years, the company retailed its products under the brand name HMV which was synonymous with film music in India. HMV is a UK-based music and film retailer (registered in England as Sunrise Records and Entertainment Ltd). From 2000 onwards, it started retailing its products under the brand name, Saregama.

About Airbus

As a proven leader in the global aerospace sector, Airbus designs, produces and delivers innovative solutions with the aim to create a better-connected, safer and more prosperous world. These cutting-edge products and services – which span the commercial aircraft, helicopter, defence, security and space segments – benefit from our wide-ranging expertise and continued emphasis on innovation. A commercial aircraft manufacturer, with Space and Defence as well as Helicopters Divisions, Airbus is the largest aeronautics and space company in Europe and a worldwide leader. Airbus has built on its strong European heritage to become truly international – with roughly 180 locations and 12,000 direct suppliers globally. The company has aircraft and helicopter final assembly lines across Asia, Europe and the Americas, and has achieved a more than sixfold order book increase since 2000.

Website Link:

For further information
Aladdin Healthcare Technologies Ltd.
24-26 Baltic Street West
London EC1Y 0UR
Phone +44 7714 719696

Contact Press
CROSS ALLIANCE communication GmbH
Susan Hoffmeister
Phone +49 89 1250 90330